IBACNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends September 30Also trades as IBACR
IB Acquisition Corp.
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$10.86+0.00 (0.00%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Share price
+$0.38 (+3.63%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Jun 30, 2026
Valuation
- Market cap
- –
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Net income
- -$399.57K
Four years at a glance
Fiscal years 2022 to 2025 and trailing twelve months, USD
Operating income
-$1.79M
Net income
-$399.57K-111.1% YoY
Reported periodTrailing twelve months